ebselen has been researched along with meropenem in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, EWC; Chan, KF; Chan, TH; Chen, S; Cheng, Q; Gao, W; Jin, WB; Leung, YC; Qi, XL; Wong, KY; Xu, C; Zheng, Z | 1 |
| Bai, W; Cheng, K; Gao, Y; Guo, H; He, W; Li, C; Li, Z; Wu, C | 1 |
| Chan, EW; Chan, KF; Chan, TH; Chen, S; Chiou, J; He, D; So, PK; Tao, J; Wan, S; Wong, KY | 1 |
3 other study(ies) available for ebselen and meropenem
| Article | Year |
|---|---|
Investigation of synergistic antimicrobial effects of the drug combinations of meropenem and 1,2-benzisoselenazol-3(2H)-one derivatives on carbapenem-resistant Enterobacteriaceae producing NDM-1.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; HeLa Cells; Humans; Meropenem; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship; Thienamycins | 2018 |
A novel potent metal-binding NDM-1 inhibitor was identified by fragment virtual, SPR and NMR screening.
Topics: Anti-Bacterial Agents; beta-Lactamases; Coordination Complexes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Surface Plasmon Resonance; Zinc | 2020 |
Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1).
Topics: Ampicillin; Anti-Bacterial Agents; Azoles; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Isoindoles; Meropenem; Microbial Sensitivity Tests; Organoselenium Compounds; Thienamycins | 2015 |